NO178784C - Fremgangsmåte for fremstilling av et transdermalt terapeutisk system med norpseudoefedrin som virkestoff - Google Patents

Fremgangsmåte for fremstilling av et transdermalt terapeutisk system med norpseudoefedrin som virkestoff

Info

Publication number
NO178784C
NO178784C NO895173A NO895173A NO178784C NO 178784 C NO178784 C NO 178784C NO 895173 A NO895173 A NO 895173A NO 895173 A NO895173 A NO 895173A NO 178784 C NO178784 C NO 178784C
Authority
NO
Norway
Prior art keywords
norpseudoephedrine
therapeutic system
transdermal therapeutic
preparation
active ingredient
Prior art date
Application number
NO895173A
Other languages
English (en)
Norwegian (no)
Other versions
NO178784B (no
NO895173L (no
NO895173D0 (no
Inventor
Thomas Hille
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO895173D0 publication Critical patent/NO895173D0/no
Publication of NO895173L publication Critical patent/NO895173L/no
Publication of NO178784B publication Critical patent/NO178784B/no
Publication of NO178784C publication Critical patent/NO178784C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO895173A 1988-12-22 1989-12-21 Fremgangsmåte for fremstilling av et transdermalt terapeutisk system med norpseudoefedrin som virkestoff NO178784C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3843237A DE3843237A1 (de) 1988-12-22 1988-12-22 Transdermales therapeutisches system mit einem antiadipositum als aktivem bestandteil

Publications (4)

Publication Number Publication Date
NO895173D0 NO895173D0 (no) 1989-12-21
NO895173L NO895173L (no) 1990-06-25
NO178784B NO178784B (no) 1996-02-26
NO178784C true NO178784C (no) 1996-06-05

Family

ID=6369853

Family Applications (1)

Application Number Title Priority Date Filing Date
NO895173A NO178784C (no) 1988-12-22 1989-12-21 Fremgangsmåte for fremstilling av et transdermalt terapeutisk system med norpseudoefedrin som virkestoff

Country Status (23)

Country Link
EP (1) EP0374725B1 (ko)
JP (1) JP2602108B2 (ko)
KR (1) KR950015055B1 (ko)
AT (1) ATE93147T1 (ko)
AU (1) AU614208B2 (ko)
CA (1) CA2006425C (ko)
CS (1) CS275356B2 (ko)
DD (1) DD290581A5 (ko)
DE (2) DE3843237A1 (ko)
DK (1) DK651089A (ko)
ES (1) ES2045369T3 (ko)
FI (1) FI95772C (ko)
HU (1) HU203280B (ko)
IE (1) IE63878B1 (ko)
IL (1) IL92678A (ko)
MY (1) MY105074A (ko)
NO (1) NO178784C (ko)
NZ (1) NZ231909A (ko)
PH (1) PH25854A (ko)
PL (1) PL163292B1 (ko)
PT (1) PT92650B (ko)
YU (1) YU47075B (ko)
ZA (1) ZA899879B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939376C1 (ko) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
DE4342893C2 (de) * 1993-12-16 1999-09-23 Lohmann Gmbh & Co Kg Reversibel haftende, rückstandsfrei wieder ablösbare Haftklebemasse, Verfahren zu deren Herstellung und Verwendung als wiederverklebbare Haftklebeartikel
AU2727801A (en) * 1999-12-16 2001-06-25 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
KR100956865B1 (ko) * 2009-08-10 2010-05-11 주식회사 라이트론 슬라이드 가압패킹식 리니어 조명장치
US20190298661A1 (en) * 2016-10-31 2019-10-03 The Corporation Of Mercer University Transdermal Delivery of Phenethylamine Monoamine Releasers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS60185713A (ja) * 1984-03-05 1985-09-21 Nitto Electric Ind Co Ltd 経皮吸収性製剤及びその製法
EP0156080B2 (en) * 1984-03-05 1993-10-20 Nitto Denko Corporation Percutaneous absorption type adhesive pharmaceutical preparation
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
DE3629304A1 (de) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
CS8907193A3 (en) 1992-02-19
CA2006425C (en) 1995-09-05
AU614208B2 (en) 1991-08-22
IL92678A (en) 1994-06-24
PT92650A (pt) 1990-06-29
JP2602108B2 (ja) 1997-04-23
FI95772B (fi) 1995-12-15
ZA899879B (en) 1990-09-26
ES2045369T3 (es) 1994-01-16
CA2006425A1 (en) 1990-06-22
PH25854A (en) 1991-12-02
IE63878B1 (en) 1995-06-14
EP0374725A3 (en) 1990-12-19
KR950015055B1 (ko) 1995-12-21
JPH03123728A (ja) 1991-05-27
DE3843237C2 (ko) 1991-04-11
DE58905320D1 (de) 1993-09-23
EP0374725A2 (de) 1990-06-27
PT92650B (pt) 1995-09-12
ATE93147T1 (de) 1993-09-15
HUT53517A (en) 1990-11-28
NZ231909A (en) 1991-06-25
IL92678A0 (en) 1990-09-17
NO178784B (no) 1996-02-26
EP0374725B1 (de) 1993-08-18
FI896097A0 (fi) 1989-12-19
DK651089D0 (da) 1989-12-20
IE894077L (en) 1990-06-22
DE3843237A1 (de) 1990-07-05
DK651089A (da) 1990-06-23
HU896721D0 (en) 1990-02-28
DD290581A5 (de) 1991-06-06
PL163292B1 (pl) 1994-03-31
MY105074A (en) 1994-07-30
KR900009063A (ko) 1990-07-02
CS275356B2 (en) 1992-02-19
AU4684389A (en) 1990-06-28
FI95772C (fi) 1996-03-25
YU47075B (sh) 1994-12-28
HU203280B (en) 1991-07-29
NO895173L (no) 1990-06-25
NO895173D0 (no) 1989-12-21
YU240589A (en) 1991-04-30

Similar Documents

Publication Publication Date Title
MY105347A (en) Transdermal therapeutic system comprising as active component buprenorphine
NO895171D0 (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff.
NO895172D0 (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff.
NO178784C (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system med norpseudoefedrin som virkestoff